Sanjay H Chotirmall is an expert in Pulmonology at Tan Tock Seng Hospital (Singapore). As of October 2026, ScienceLeadR ranks Sanjay H Chotirmall in the top 1% of experts worldwide for Bronchiectasis, and in the top 1% of experts in Singapore for Cystic Fibrosis and Pancreatic Diseases. Sanjay H Chotirmall has authored 292 publications, the most recent in 2026, and is an investigator in 2 clinical trials, 1 of them ongoing. SLR score: 1,146 (community average: 125). How the SLR is computed.

LeadR Profile

Sanjay H Chotirmall Tan Tock Seng Hospital Singapore
1 146 ScienceLeadR Reputation 1146
Network Map

Pulmonology

Subspecialties: Critical Care - Infectiology - Public Health

Full career – Last 3 years

Main Topics

Publications and Clinical Studies

Publications – Clinical Studies

Profile data updated on

Organizations

Career arc: 2008 - 2026

Source: PubMed

Nanyang Technological University

Publications Synthesis

Sources: PubMed, OpenAlex

Breakdown by type

Click a legend label to hide or show it in the chart.

Latest Publications

5 most recent indexed articles

Source: Pubmed

Title Journal Year Citations
Phase III AIRTIVITY study design: verducatib (BI 1291583) in people with bronchiectasis.
PMID 42820152 — safety, bronchiectasis
ERJ Open Res20261
Axial Connectivity of the Lung Microbiome: A Review of Interorgan Crosstalk.
PMID 42763526 — lung, therapeutics, lung diseases
Compr Physiol20260
Pseudomonas Aeruginosa Abundotypes and Interactotypes Reflect Clinical Heterogeneity in Bronchiectasis.
PMID 42726103 — respiratory tract diseases, pseudomonas, critical care, pseudomonas aeruginosa, therapeutics, bronchiectasis
Am J Respir Crit Care Med20260
Association of Easier Biologic Access with Remission and Other Clinical Outcomes in Severe Asthma: A Global Real-World Study.
PMID 42638984 — therapeutics, asthma
J Asthma Allergy20260
To the Airway and Beyond: Introduction to an AJRCCM Special Section on Airway Disease.
PMID 42518197 — critical care
Am J Respir Crit Care Med20260

Clinical Studies 2

Sources: ClinicalTrials, EU CTIS

Synthesis

By phase:

Phase 2 1
Phase 3 1

By status:

Completed 1
Recruiting 1

By type:

Interventional 2

By Monocentric/Multicentric:

monocentric 0
multicentric2to4 0
multicentric5to9 0
multicentricup10 2

Main Topics

Ongoing Clinical Trials

Ongoing trial started since 2021, where this expert is an investigator

Source: ClinicalTrials

Study Phase Status Start
The AIRTIVITY Study A Study to Find Out Whether BI 1291583 Helps People With Bronchiectasis
NCT06872892 — safety, tablets, bronchiectasis
Phase 3Recruiting2025

LeadR Networks

Main global connection map